fenben for humans
A broad spectrum anti-parasitic drug used as an animal dewormer has been found to prevent cancer cells from absorbing glucose, keeping them from growing. It also has anti-tumor properties, researchers found in a study published in Scientific Reports. The researchers say the results could lead to a new treatment for colon, breast and prostate cancers and possibly other types of tumors.
Fenbendazole (FZ), which is in the benzimidazole family of drugs, interferes with host energy metabolism and is toxic to many parasitic organisms. They found that it prevented the proliferation of human lung cancer cell lines H460 and A549, and inhibited glucose uptake in both cell types. It also prevented tumor vascularity by decreasing hemoglobin content in a spectrophotometric assay of tumors.
Earlier in 2019, a veterinarian’s videos that promoted the use of the canine deworming medication to cure cancer made waves on social media, particularly on TikTok. The video series starring Andrew Jones, who claims to be a Canadian small-cell cancer survivor, has since been removed from the platform. He was reprimanded by the College of Veterinarians in British Columbia for promoting alternative medicine and for making claims that were not supported by evidence.
Another benzimidazole, mebendazole, has been found to have similar anti-cancer effects as fenbendazole. It can be taken in combination with other immunotherapies, such as chemo and radiation, to improve the effectiveness of the treatment for cancer patients. Talk to your integrative oncology nurse about the possibility of using fenbendazole or mebendazole for your specific cancer.fenben for humans